News Snapshot:
US, China and Japan investors back $37m PetMedix Series B Heavyweight Chinese, Japanese and US backing has allowed Cambridge animal healthtech company PetMedix™ to complete an oversubscribed $37 million Series B round to advance its innovative pipeline through clinical development. And the Babraham-based company is looking for more. The investment brings two new investors into PetMedix – global technology company Tencent and Japanese corporation Kyoritsu Holdings alongside strong continued support from US-based investor Digitalis Ventures and British funds Parkwalk Advisors and Cambridge Innovation Capital. The money enables PetMedix to take its next step towards becoming a truly global animal health...
